Swedish MedTech company MYoroface expands – innovative medical treatment for reflux now launched across the entire Nordic region
MYoroface is the Swedish MedTech company behind the unique innovation IQoro which treats the underlying cause of acid reflux, heartburn and more. IQoro has now been launched across all Nordic markets. Through a farsighted long-term global expansion strategy, the company wants to eventually address the fifth of the world’s population that suffer from acid reflux. […]Read more
A CE Mark is needed in order to introduce a MedTech product into the EU and currently the UK markets. Starting from 26th May 2021 the new MDR regulations 2017/745 will apply. These set higher demands on suppliers, but what will they mean for consumers? A summary of the new MDR regulations Increased demand for […]Read more
New neuromuscular treatment for Hiatus hernia shortens intervention times for Healthcare Professionals and patients
Swedish Associate Professors Thomas Franzén and Mary Hägg have written a book chapter for IntechOpen, the world’s leading publisher of Open Access books. The conclusions are that reflux is most commonly caused by Hiatus hernia and that this can be treated successfully with neuromuscular training. The treatment also shortens intervention times for Healthcare Professionals as […]Read more
Swedish neuromuscular training device referenced in NICE pathway for treatment of reflux diseases in the NHS
In the UK, the National Health Service (NHS) is advised by, amongst others, The National Institute for Health and Care Excellence (NICE), who provide national guidance and advice to improve health and social care, have updated guidelines on two pathways that recommend treatments for reflux diseases. Both highlight IQoro as a treatment: – Managing gastro-oesophageal reflux […]Read more
Scientist, innovator and registered dentist Mary Hägg has recently been awarded the title of Docent/Associate Professor in experimental ear, nose and throat diseases at Uppsala University. Her wide-ranging research centres on neuromuscular training and how it can be used to treat a range of conditions from Hiatus hernia, reflux and sleep apnoea to speech and […]Read more
The UK Stroke Forum, one of the largest European forums for researchers in stroke care, took place in December 2020. Among the 230 scientific studies submitted to the event, a jury selected a study on dysphagia by Dr Mary Hägg of Uppsala University as winner of “Best Poster” prize. Every year more than 100,000 people […]Read more
Despite the fact that 2020 has been a year of crises and a shaky world economy, MYoroface is doing better than ever. During this year, the Swedish MedTech company has increased its sales by 50%. The workforce has doubled and an expansion in the European market is just around the corner. MYoroface is a Swedish […]Read more
More than 20% of the world’s population suffer from reflux and endure symptoms like heartburn, acid reflux and thick phlegm. In many cases so severely that it is difficult to eat normally – or even to lie down and sleep. To draw attention to this global problem MYoroface AB, manufacturer of IQoro, has instituted International […]Read more
Swedish Medtech innovation takes up the fight against medicines with serious side effects, and unnecessary surgical interventions
Globally, more than 400 million people suffer from reflux. A Swedish innovation – a neuromuscular training device – is leading the fight against both expensive surgical procedures and long term use of medicines that are connected to a range of serious side effects. Millions of people take Proton Pump Inhibitor (PPI) medications every day for […]Read more
The difference is like night and day compared with when I began.
11. Effect of IQoro training on impaired postural control and oropharyngeal motor function in patients with dysphagia after stroke.
IQoro successfully treats impaired postural control and oropharyngeal motor function in patients with dysphagia after stroke. The study show improvements are still present at long-term follow up.Read more
8. Effect of oral IQoro and palatal plate training in post-stroke, four-quadrant facial dysfunction and dysphagia: A comparison study.
This comparising study shows there is little difference between the effectiveness of palatal plate and IQoro neuromuscular treatments, but large practical and economic advantages in using IQoro.Read more